Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-08-055199
Filing Date
2008-09-29
Accepted
2008-09-29 17:30:35
Documents
6
Period of Report
2008-06-30

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT v127505_10k.htm 10-K 2541161
2 GRAPHIC str.jpg GRAPHIC 46469
3 CERTIFICATION - SECTION 302 - CEO v127505_ex31-1.htm EX-31.1 11957
4 CERTIFICATION - SECTION 302 - CFO v127505_ex31-2.htm EX-31.2 11645
5 CERTIFICATION - SECTION 906 - CEO v127505_ex32-1.htm EX-32.1 6904
6 CERTIFICATION - SECTION 906 - CFO v127505_ex32-2.htm EX-32.2 6885
  Complete submission text file 0001144204-08-055199.txt   2644492
Mailing Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075
Business Address MIDDLE SECTION, LONGMAO STREET, AREA A LAIYANG WAIXIANGXING INDUSTRIAL PARK LAIYANG CITY, YANTAI F4 710075 5619889880
Genesis Pharmaceuticals Enterprises, Inc. (Filer) CIK: 0001091164 (see all company filings)

EIN.: 651130026 | State of Incorp.: FL | Fiscal Year End: 0930
Type: 10-K | Act: 34 | File No.: 000-53037 | Film No.: 081095627
SIC: 2834 Pharmaceutical Preparations